Clinical Trial Update: Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation [Phase 4]

View source ↗

Summary

Phase 4 study update on the long-term effects of somatropin in subjects with intrauterine growth retardation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Retardation
• Small For Gestational Age

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Foetal Growth Problem, Small for Gestational Age | Phase 4 | Status: COMPLETED